Back to search

Article

Network pharmacology analysis of ZiShenWan for diabetic nephropathy and experimental verification of its anti-inflammatory mechanism

2020-12-15

Abstract excerpt

<h4>Background: </h4> Diabetic nephropathy (DN) is the leading cause of end-stage renal disease (ESRD). The inflammatory response plays a critical role in the process of DN. ZiShenWan (ZSW) is a classical Chinese medicinal formula with remarkable clinical therapeutic effects on DN, but its pharmacological action mechanisms remain unclear. <h4>Methods:</h4> In this study, a network pharmacology approach was applied...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a4f22a11-acc6-501f-a3cd-718e566015ae
DOI
10.21203/rs.3.rs-127749/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Network pharmacology analysis of ZiShenWan for diabetic nephropathy and experimental verification of its anti-inflammatory mechanismDOI 10.21203/rs.3.rs-127749/v1
Select a neighboring publication to make it the new centre.